Health
Body’s immune response drives production of non-functional COVID ‘gateway protein’: Study – Times of India
In the study, scientists, including those from the Francis Crick Institute in London, analysed existing genetic dat
Some immune system molecules trigger the production of a non-functional variant of the human protein used by the novel coronavirus to enter and infect host cells, according to a study that sheds light on the body’s natural defence against COVID-19. The research, published in the journal Nature Genetics, examined the genetic information that codes for the ACE2 receptor, to which the SARS-CoV-2 virus must bind in order to enter and infect human cells.
In the study, scientists, including those from…
-
Noosa News23 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
General24 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News24 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Business24 hours agoWhy last week’s market selloff is a gift for beginner ASX investors